IBDEI090 ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22037,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,22037,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,22038,0)
 ;;=G44.209^^73^938^8
 ;;^UTILITY(U,$J,358.3,22038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22038,1,3,0)
 ;;=3^Tension-Type Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,22038,1,4,0)
 ;;=4^G44.209
 ;;^UTILITY(U,$J,358.3,22038,2)
 ;;=^5003936
 ;;^UTILITY(U,$J,358.3,22039,0)
 ;;=I30.0^^73^939^5
 ;;^UTILITY(U,$J,358.3,22039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22039,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,22039,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,22039,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,22040,0)
 ;;=I34.8^^73^939^6
 ;;^UTILITY(U,$J,358.3,22040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22040,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
 ;;^UTILITY(U,$J,358.3,22040,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,22040,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,22041,0)
 ;;=I34.0^^73^939^13
 ;;^UTILITY(U,$J,358.3,22041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22041,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,22041,1,4,0)
 ;;=4^I34.0
 ;;^UTILITY(U,$J,358.3,22041,2)
 ;;=^5007169
 ;;^UTILITY(U,$J,358.3,22042,0)
 ;;=I34.9^^73^939^12
 ;;^UTILITY(U,$J,358.3,22042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22042,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,22042,1,4,0)
 ;;=4^I34.9
 ;;^UTILITY(U,$J,358.3,22042,2)
 ;;=^5007173
 ;;^UTILITY(U,$J,358.3,22043,0)
 ;;=I34.2^^73^939^7
 ;;^UTILITY(U,$J,358.3,22043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22043,1,3,0)
 ;;=3^Nonrhematic Mitral Valve Stenosis
 ;;^UTILITY(U,$J,358.3,22043,1,4,0)
 ;;=4^I34.2
 ;;^UTILITY(U,$J,358.3,22043,2)
 ;;=^5007171
 ;;^UTILITY(U,$J,358.3,22044,0)
 ;;=I35.0^^73^939^10
 ;;^UTILITY(U,$J,358.3,22044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22044,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,22044,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,22044,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,22045,0)
 ;;=I35.1^^73^939^9
 ;;^UTILITY(U,$J,358.3,22045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22045,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,22045,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,22045,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,22046,0)
 ;;=I35.2^^73^939^11
 ;;^UTILITY(U,$J,358.3,22046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22046,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,22046,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,22046,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,22047,0)
 ;;=I35.9^^73^939^8
 ;;^UTILITY(U,$J,358.3,22047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22047,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,22047,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,22047,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,22048,0)
 ;;=I38.^^73^939^4
 ;;^UTILITY(U,$J,358.3,22048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22048,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,22048,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,22048,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,22049,0)
 ;;=I05.0^^73^939^18
 ;;^UTILITY(U,$J,358.3,22049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22049,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,22049,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,22049,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,22050,0)
 ;;=I05.8^^73^939^19
 ;;^UTILITY(U,$J,358.3,22050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22050,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,22050,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,22050,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,22051,0)
 ;;=I05.9^^73^939^20
 ;;^UTILITY(U,$J,358.3,22051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22051,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,22051,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,22051,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,22052,0)
 ;;=I07.1^^73^939^21
 ;;^UTILITY(U,$J,358.3,22052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22052,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,22052,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,22052,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,22053,0)
 ;;=I07.9^^73^939^22
 ;;^UTILITY(U,$J,358.3,22053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22053,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,22053,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,22053,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,22054,0)
 ;;=I08.0^^73^939^16
 ;;^UTILITY(U,$J,358.3,22054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22054,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,22054,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,22054,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,22055,0)
 ;;=I09.89^^73^939^17
 ;;^UTILITY(U,$J,358.3,22055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22055,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,22055,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,22055,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,22056,0)
 ;;=I47.1^^73^939^24
 ;;^UTILITY(U,$J,358.3,22056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22056,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,22056,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,22056,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,22057,0)
 ;;=I48.0^^73^939^15
 ;;^UTILITY(U,$J,358.3,22057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22057,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,22057,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,22057,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,22058,0)
 ;;=I49.5^^73^939^23
 ;;^UTILITY(U,$J,358.3,22058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22058,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,22058,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,22058,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,22059,0)
 ;;=I49.8^^73^939^3
 ;;^UTILITY(U,$J,358.3,22059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22059,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,22059,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,22059,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,22060,0)
 ;;=I49.9^^73^939^2
 ;;^UTILITY(U,$J,358.3,22060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22060,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,22060,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,22060,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,22061,0)
 ;;=R00.1^^73^939^1
 ;;^UTILITY(U,$J,358.3,22061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22061,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,22061,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,22061,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,22062,0)
 ;;=I34.1^^73^939^14
 ;;^UTILITY(U,$J,358.3,22062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22062,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,22062,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,22062,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,22063,0)
 ;;=D68.4^^73^940^1
 ;;^UTILITY(U,$J,358.3,22063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22063,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,22063,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,22063,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,22064,0)
 ;;=D59.9^^73^940^2
 ;;^UTILITY(U,$J,358.3,22064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22064,1,3,0)
 ;;=3^Acquired Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,22064,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,22064,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,22065,0)
 ;;=C91.00^^73^940^5
 ;;^UTILITY(U,$J,358.3,22065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22065,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,22065,1,4,0)
 ;;=4^C91.00
 ;;^UTILITY(U,$J,358.3,22065,2)
 ;;=^5001762
 ;;^UTILITY(U,$J,358.3,22066,0)
 ;;=C91.01^^73^940^4
 ;;^UTILITY(U,$J,358.3,22066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22066,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,22066,1,4,0)
 ;;=4^C91.01
 ;;^UTILITY(U,$J,358.3,22066,2)
 ;;=^5001763
 ;;^UTILITY(U,$J,358.3,22067,0)
 ;;=C92.01^^73^940^7
 ;;^UTILITY(U,$J,358.3,22067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22067,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,22067,1,4,0)
 ;;=4^C92.01
 ;;^UTILITY(U,$J,358.3,22067,2)
 ;;=^5001790
 ;;^UTILITY(U,$J,358.3,22068,0)
 ;;=C92.00^^73^940^8
 ;;^UTILITY(U,$J,358.3,22068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22068,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,22068,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,22068,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,22069,0)
 ;;=C92.61^^73^940^9
 ;;^UTILITY(U,$J,358.3,22069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22069,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
 ;;^UTILITY(U,$J,358.3,22069,1,4,0)
 ;;=4^C92.61
 ;;^UTILITY(U,$J,358.3,22069,2)
 ;;=^5001808
 ;;^UTILITY(U,$J,358.3,22070,0)
 ;;=C92.60^^73^940^10
 ;;^UTILITY(U,$J,358.3,22070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22070,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
 ;;^UTILITY(U,$J,358.3,22070,1,4,0)
 ;;=4^C92.60
 ;;^UTILITY(U,$J,358.3,22070,2)
 ;;=^5001807
 ;;^UTILITY(U,$J,358.3,22071,0)
 ;;=C92.A1^^73^940^11
 ;;^UTILITY(U,$J,358.3,22071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22071,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
 ;;^UTILITY(U,$J,358.3,22071,1,4,0)
 ;;=4^C92.A1
 ;;^UTILITY(U,$J,358.3,22071,2)
 ;;=^5001814
 ;;^UTILITY(U,$J,358.3,22072,0)
 ;;=C92.A0^^73^940^12
 ;;^UTILITY(U,$J,358.3,22072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22072,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
 ;;^UTILITY(U,$J,358.3,22072,1,4,0)
 ;;=4^C92.A0
 ;;^UTILITY(U,$J,358.3,22072,2)
 ;;=^5001813
 ;;^UTILITY(U,$J,358.3,22073,0)
 ;;=C92.51^^73^940^13
 ;;^UTILITY(U,$J,358.3,22073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22073,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,22073,1,4,0)
 ;;=4^C92.51
 ;;^UTILITY(U,$J,358.3,22073,2)
 ;;=^5001805
 ;;^UTILITY(U,$J,358.3,22074,0)
 ;;=C92.50^^73^940^14
 ;;^UTILITY(U,$J,358.3,22074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22074,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,22074,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,22074,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,22075,0)
 ;;=C94.40^^73^940^17
 ;;^UTILITY(U,$J,358.3,22075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22075,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
 ;;^UTILITY(U,$J,358.3,22075,1,4,0)
 ;;=4^C94.40
 ;;^UTILITY(U,$J,358.3,22075,2)
 ;;=^5001843
 ;;^UTILITY(U,$J,358.3,22076,0)
 ;;=C94.42^^73^940^15
 ;;^UTILITY(U,$J,358.3,22076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22076,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
 ;;^UTILITY(U,$J,358.3,22076,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,22076,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,22077,0)
 ;;=C94.41^^73^940^16
 ;;^UTILITY(U,$J,358.3,22077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22077,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
 ;;^UTILITY(U,$J,358.3,22077,1,4,0)
 ;;=4^C94.41
 ;;^UTILITY(U,$J,358.3,22077,2)
 ;;=^5001844
 ;;^UTILITY(U,$J,358.3,22078,0)
 ;;=D62.^^73^940^18
 ;;^UTILITY(U,$J,358.3,22078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22078,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,22078,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,22078,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,22079,0)
 ;;=C92.41^^73^940^19
 ;;^UTILITY(U,$J,358.3,22079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22079,1,3,0)
 ;;=3^Acute Promyelocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,22079,1,4,0)
 ;;=4^C92.41
 ;;^UTILITY(U,$J,358.3,22079,2)
 ;;=^5001802
 ;;^UTILITY(U,$J,358.3,22080,0)
 ;;=C92.40^^73^940^20
 ;;^UTILITY(U,$J,358.3,22080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22080,1,3,0)
 ;;=3^Acute Promyelocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,22080,1,4,0)
 ;;=4^C92.40
 ;;^UTILITY(U,$J,358.3,22080,2)
 ;;=^5001801
 ;;^UTILITY(U,$J,358.3,22081,0)
 ;;=D56.0^^73^940^21
 ;;^UTILITY(U,$J,358.3,22081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22081,1,3,0)
 ;;=3^Alpha Thalassemia
 ;;^UTILITY(U,$J,358.3,22081,1,4,0)
 ;;=4^D56.0
 ;;^UTILITY(U,$J,358.3,22081,2)
 ;;=^340494
 ;;^UTILITY(U,$J,358.3,22082,0)
 ;;=D63.1^^73^940^23
 ;;^UTILITY(U,$J,358.3,22082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22082,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,22082,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,22082,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,22083,0)
 ;;=D63.0^^73^940^24
 ;;^UTILITY(U,$J,358.3,22083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22083,1,3,0)
 ;;=3^Anemia in Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,22083,1,4,0)
 ;;=4^D63.0
 ;;^UTILITY(U,$J,358.3,22083,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,22084,0)
 ;;=D63.8^^73^940^22
 ;;^UTILITY(U,$J,358.3,22084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22084,1,3,0)
 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,22084,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,22084,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,22085,0)
 ;;=C22.3^^73^940^27
 ;;^UTILITY(U,$J,358.3,22085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22085,1,3,0)
 ;;=3^Angiosarcoma of Liver
 ;;^UTILITY(U,$J,358.3,22085,1,4,0)
 ;;=4^C22.3
 ;;^UTILITY(U,$J,358.3,22085,2)
 ;;=^5000936
 ;;^UTILITY(U,$J,358.3,22086,0)
 ;;=D61.9^^73^940^28
 ;;^UTILITY(U,$J,358.3,22086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22086,1,3,0)
 ;;=3^Aplastic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,22086,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,22086,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,22087,0)
 ;;=D56.1^^73^940^30
 ;;^UTILITY(U,$J,358.3,22087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22087,1,3,0)
 ;;=3^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,22087,1,4,0)
 ;;=4^D56.1
 ;;^UTILITY(U,$J,358.3,22087,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,22088,0)
 ;;=C83.79^^73^940^32
 ;;^UTILITY(U,$J,358.3,22088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22088,1,3,0)
 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22088,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,22088,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,22089,0)
 ;;=C83.70^^73^940^33
 ;;^UTILITY(U,$J,358.3,22089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22089,1,3,0)
 ;;=3^Burkitt Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,22089,1,4,0)
 ;;=4^C83.70
 ;;^UTILITY(U,$J,358.3,22089,2)
 ;;=^5001591
 ;;^UTILITY(U,$J,358.3,22090,0)
 ;;=D09.0^^73^940^40
 ;;^UTILITY(U,$J,358.3,22090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22090,1,3,0)
 ;;=3^Carcinoma in Situ of Bladder
 ;;^UTILITY(U,$J,358.3,22090,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,22090,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,22091,0)
 ;;=D06.9^^73^940^41
 ;;^UTILITY(U,$J,358.3,22091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22091,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix
 ;;^UTILITY(U,$J,358.3,22091,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,22091,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,22092,0)
 ;;=D06.0^^73^940^43
 ;;^UTILITY(U,$J,358.3,22092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22092,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,22092,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,22092,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,22093,0)
 ;;=D06.1^^73^940^44
 ;;^UTILITY(U,$J,358.3,22093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22093,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,22093,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,22093,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,22094,0)
 ;;=D06.7^^73^940^42
 ;;^UTILITY(U,$J,358.3,22094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22094,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Other Parts
 ;;^UTILITY(U,$J,358.3,22094,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,22094,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,22095,0)
 ;;=D04.9^^73^940^45
 ;;^UTILITY(U,$J,358.3,22095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22095,1,3,0)
 ;;=3^Carcinoma in Situ of Skin
 ;;^UTILITY(U,$J,358.3,22095,1,4,0)
 ;;=4^D04.9
 ;;^UTILITY(U,$J,358.3,22095,2)
 ;;=^5001925
 ;;^UTILITY(U,$J,358.3,22096,0)
 ;;=C91.11^^73^940^48
 ;;^UTILITY(U,$J,358.3,22096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22096,1,3,0)
 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,In Remission
 ;;^UTILITY(U,$J,358.3,22096,1,4,0)
 ;;=4^C91.11
 ;;^UTILITY(U,$J,358.3,22096,2)
 ;;=^5001766
 ;;^UTILITY(U,$J,358.3,22097,0)
 ;;=C91.10^^73^940^49
 ;;^UTILITY(U,$J,358.3,22097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22097,1,3,0)
 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,Not in Remission
 ;;^UTILITY(U,$J,358.3,22097,1,4,0)
 ;;=4^C91.10
 ;;^UTILITY(U,$J,358.3,22097,2)
 ;;=^5001765
 ;;^UTILITY(U,$J,358.3,22098,0)
 ;;=C92.11^^73^940^50
 ;;^UTILITY(U,$J,358.3,22098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22098,1,3,0)
 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,In Remission
 ;;^UTILITY(U,$J,358.3,22098,1,4,0)
 ;;=4^C92.11
 ;;^UTILITY(U,$J,358.3,22098,2)
 ;;=^5001793
 ;;^UTILITY(U,$J,358.3,22099,0)
 ;;=C92.10^^73^940^51
 ;;^UTILITY(U,$J,358.3,22099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22099,1,3,0)
 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,Not in Remission
 ;;^UTILITY(U,$J,358.3,22099,1,4,0)
 ;;=4^C92.10
 ;;^UTILITY(U,$J,358.3,22099,2)
 ;;=^5001792
 ;;^UTILITY(U,$J,358.3,22100,0)
 ;;=D47.1^^73^940^52
 ;;^UTILITY(U,$J,358.3,22100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22100,1,3,0)
 ;;=3^Chronic Myeloproliferative Disease
 ;;^UTILITY(U,$J,358.3,22100,1,4,0)
 ;;=4^D47.1
 ;;^UTILITY(U,$J,358.3,22100,2)
 ;;=^5002256
 ;;^UTILITY(U,$J,358.3,22101,0)
 ;;=C82.69^^73^940^53
 ;;^UTILITY(U,$J,358.3,22101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22101,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22101,1,4,0)
 ;;=4^C82.69
 ;;^UTILITY(U,$J,358.3,22101,2)
 ;;=^5001530
 ;;^UTILITY(U,$J,358.3,22102,0)
 ;;=C82.60^^73^940^54
 ;;^UTILITY(U,$J,358.3,22102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22102,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,22102,1,4,0)
 ;;=4^C82.60
 ;;^UTILITY(U,$J,358.3,22102,2)
 ;;=^5001521
 ;;^UTILITY(U,$J,358.3,22103,0)
 ;;=D56.2^^73^940^55
 ;;^UTILITY(U,$J,358.3,22103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22103,1,3,0)
 ;;=3^Delta-Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,22103,1,4,0)
 ;;=4^D56.2
 ;;^UTILITY(U,$J,358.3,22103,2)
 ;;=^340496
 ;;^UTILITY(U,$J,358.3,22104,0)
 ;;=D75.9^^73^940^56
 ;;^UTILITY(U,$J,358.3,22104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22104,1,3,0)
 ;;=3^Disease of Blood/Blood-Forming Organs,Unspec
 ;;^UTILITY(U,$J,358.3,22104,1,4,0)
 ;;=4^D75.9
 ;;^UTILITY(U,$J,358.3,22104,2)
 ;;=^5002393
 ;;^UTILITY(U,$J,358.3,22105,0)
 ;;=D59.0^^73^940^59
